Meta-analysis on effect of esketamine in combination with remazolam besylate for patients taking endoscopic retrograde cholangiopancreatography

doi:10.3760/cma.j.issn.1007-1245.2024.07.009

Abstract

Abstract:

Objective　To systematically review the effect of esketamine in combination with remazolam besylate for patients taking endoscopic retrograde cholangiopancreatography(ERCP). Methods　The randomized controlled trials (RCTs) on esketamine and remimazolam besylate for patients taking ERCP published at CNKI, VIP, Wanfang, PubMed, Web of Science, Embase, and the Cochrance Library from their establishment to March 2023 were searched. The experimental group was anesthetized with the combination of ketamine and remifentanil besylate for ERCP, while the control group with other intravenous anesthetics. Two unrelated researchers carefully screened the literatures based on the inclusion and exclusion criteria, and conducted statistical analysis using the Review Manager 5.4 software. Results　Six RCTs were included, with a total of 532 patients. Compared with other anesthesia drug regimens, the esketamine combined with remazolam besylate group had lower probabilities of hypotension and respiratory depression (RR=0.29, 95%CI 0.17～0.50; RR=0.18,95%CI 0.08～0.38). Conclusion　The combined use of ketamine and remazolam besylate for patients taking ERCP can significantly reduce the probability of adverse events, and is a more stable and safer anesthesia method.

Key words:

Endoscopic retrograde cholangiopancreatography, Remazolam besylate, Esketamine, Meta-analysis

摘要：

目的　系统评价艾司氯胺酮与苯磺酸瑞马唑仑联合使用对内镜逆行胰胆管造影术（ERCP）患者的影响。方法　检索中国知网、维普、万方、PubMed、Web of science、Embase及Cochrance图书馆的数据库，从建库到2023年3月发表的艾司氯胺酮联合苯磺酸瑞马唑仑用于ERCP的随机对照试验（RCTs）。试验组采用艾司氯胺酮复合苯磺酸瑞马唑仑的麻醉方案，对照组采用其他静脉麻醉药物联合使用方案。由互不关联的2名研究者根据纳入排除标准对文献进行仔细筛选，使用Review Manager 5.4软件进行统计分析。结果　纳入6项RCTs，共532例患者。与其他麻醉药物联合使用方案比较，艾司氯胺酮联合苯磺酸瑞马唑仑组患者发生低血压、呼吸抑制等不良事件的概率更低（RR=0.29，95%CI 0.17～0.50；RR=0.18，95%CI 0.08～0.38）。结论　采用艾司氯胺酮联合苯磺酸瑞马唑仑能减少患者ERCP中的不良事件发生概率，是一种更平稳、安全的麻醉方法。

关键词:

内镜逆行胰胆管造影术, 苯磺酸瑞马唑仑, 艾司氯胺酮, meta分析

Si Wenli, Zhang Quanyi.

Meta-analysis on effect of esketamine in combination with remazolam besylate for patients taking endoscopic retrograde cholangiopancreatography [J]. International Medicine and Health Guidance News, 2024, 30(7): 1099-1104.

司文丽张全意.

艾司氯胺酮联合苯磺酸瑞马唑仑对ERCP患者影响的meta分析 [J]. 国际医药卫生导报, 2024, 30(7): 1099-1104.

References

[1] Yi X, Xu W, Li A. The clinical application of remimazolam benzenesulfonate combined with esketamine intravenous anesthesia in endoscopic retrograde cholangiopancreatography[J]. Biomed Res Int, 2022, 2022:5628687. DOI: 10.1155/2022/5628687.
[2] Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy[J]. Gastrointest Endosc, 2018,88(3):427-437.e6. DOI: 10.1016/j.gie.2018.04.2351.
[3] 袁柳青,李晓玲. 艾司氯胺酮复合瑞马唑仑在老年患者全身麻醉诱导中的应用[J]. 中国新药与临床杂志,2023,42(1):28-31. DOI:10.14109/j.cnki.xyylc.2023.01.06.
[4] 王晓东,于明涛,刘子强,等. 苯磺酸瑞马唑仑联合艾司氯胺酮静脉麻醉在内镜下逆行胰胆管造影术中的临床应用[J]. 中国医刊,2021,56(3):274-277. DOI:10.3969/j.issn.1008-1070.2021.03.012.
[5] 陆阳春,邱琼,王礼伟,等. 苯磺酸瑞马唑仑与艾司氯胺酮联合用于ERCP麻醉效果及对循环和呼吸指标的影响[J]. 中外医学研究,2023,21(1):37-41. DOI:10.14033/j.cnki.cfmr.2023.01.009.
[6] 李爱玲. 苯磺酸瑞马唑仑+艾司氯胺酮静脉麻醉在内镜下逆行胰胆管造影术中的实施效果[J]. 医学理论与实践,2022,35(17):2943-2945. DOI:10.19381/j.issn.1001- 7585.2022.17.025.
[7] 杨建功,赵利芳,孟瑞霞,等. 甲苯磺酸瑞马唑仑联合盐酸艾司氯胺酮麻醉对ERCP患者术中心血管应激反应及术后苏醒时间的影响[J]. 药品评价,2022,19(18):1140-1143. DOI:10.19939/j.cnki.1672-2809.2022.18.14.
[8] 曹凤林,江岸柳. 甲苯磺酸瑞马唑仑联合艾司氯胺酮静脉麻醉在内镜下逆行胰胆管造影术中的应用[J]. 医学信息,2022,35(17):123-125. DOI:10.3969/j.issn.1006- 1959.2022.17.033.
[9] van der Merwe SW, van Wanrooij RLJ, Bronswijk M, et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) guideline[J]. Endoscopy, 2022,54(2):185-205. DOI: 10.1055/a-1717-1391.
[10] Dong SA, Guo Y, Liu SS, et al. A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures[J]. J Clin Anesth, 2023,86:111077. DOI: 10.1016/j.jclinane.2023.111077.
[11] Eberl S, Koers L, van Hooft J, et al. The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography: a randomised controlled multicentre trial[J]. Eur J Anaesthesiol, 2020,37(5):394-401. DOI: 10.1097/EJA.0000000000001134.
[12] Liu J, Liu X, Peng LP, et al. Efficacy and safety of intravenous lidocaine in propofol-based sedation for ERCP procedures: a prospective, randomized, double-blinded, controlled trial[J]. Gastrointest Endosc, 2020,92(2):293-300. DOI: 10.1016/j.gie.2020.02.050.
[13] Kim DK, Yoon SH, Kim JY, et al. Comparison of the effects of sufentanil and fentanyl intravenous patient controlled analgesia after lumbar fusion[J]. J Korean Neurosurg Soc, 2017,60(1):54-59. DOI: 10.3340/jkns.2016.0707.007.
[14] Liu G, Xiong Y. Analysis of stress response and analgesic effect of remazolam combined with etomidate in painless gastroenteroscopy[J]. Contrast Media Mol Imaging, 2022,2022:4863682. DOI: 10.1155/2022/4863682.
[15] Aronsohn J, Orner G, Palleschi G, et al. Opioid-free total intravenous anesthesia with ketamine as part of an enhanced recovery protocol for bariatric surgery patients with sleep disordered breathing[J]. J Clin Anesth, 2019,52:65-66. DOI: 10.1016/j.jclinane.2018.09.014.
[16] Morena M, Berardi A, Peloso A, et al. Effects of ketamine, dexmedetomidine and propofol anesthesia on emotional memory consolidation in rats: consequences for the development of post-traumatic stress disorder[J]. Behav Brain Res, 2017,329:215-220. DOI: 10.1016/j.bbr.2017.04.048.
[17] Yang H, Zhao Q, Chen HY, et al. The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: a randomized controlled trial[J]. Br J Clin Pharmacol, 2022,88(3):1279-1287. DOI: 10.1111/bcp.15072.
[18] Schmitz A, Weiss M, Kellenberger C, et al. Sedation for magnetic resonance imaging using propofol with or without ketamine at induction in pediatrics-a prospective randomized double-blinded study[J]. Paediatr Anaesth, 2018,28(3):264-274. DOI: 10.1111/pan.13315.
[19] 王业文,刘树鹏,张全意,等.术中七氟烷维持麻醉对单肺通气患者肺内分流率影响的meta分析[J]. 国际医药卫生导报,2023,29(10):1379-1384. DOI:10.3760/cma.j.issn. 1007-1245.2023.10.011.
[20] 都淑萍,王晓东,潘红霞,等. 右美托咪定、丙泊酚联合小剂量艾司氯胺酮在宫腔镜手术中的临床应用[J]. 国际医药卫生导报,2022,28(15):2093-2097. DOI:10.3760/cma.j.issn.1007-1245.2022.15.005.
[21] 张辰喜,王鹏飞,潘欣,等. 艾司氯胺酮在临床麻醉中的应用进展[J]. 国际医药卫生导报,2023,29(23):3325-3329. DOI:10.3760/cma.j.issn.1007-1245.2023.23.002.
[22] Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis[J]. Br J Anaesth, 2014,112(5):906-911. DOI: 10.1093/bja/aet551.
[23] 刘湘杰,林华赋,程芳,等. 艾司氯胺酮对肥胖患者全身麻醉手术瑞芬太尼用量和术后疼痛的影响[J]. 国际医药卫生导报,2023,29(2):265-268. DOI:10.3760/cma.j.issn. 1007-1245.2023.02.028.
[24] 宋志永,张晓华,李泉,等. 瑞马唑仑联合阿芬太尼在老年患者无痛胃肠镜检查中的应用效果[J]. 国际医药卫生导报,2023,29(24):3625-3628. DOI:10.3760/cma.j.issn.1007- 1245.2023.24.020.